07:00 , Oct 14, 2013 |  BC Week In Review  |  Company News

Oncoceutics, Calvert Research LLC deal

Oncoceutics and investment firm Calvert will utilize Calvert's CRO affiliate, Calvert Laboratories Inc., to complete preclinical studies of Oncoceutics' ONC201 , with the goal of submitting an IND to FDA by year end. Calvert did...
02:09 , Dec 5, 2006 |  BC Extra  |  Financial News

Cylex raises $18.4 million

Cylex (Columbia, Md.) raised $18.4 million in the first closing of a series C round led by Channel Medical Partners and Canaan Partners. New investor First Analysis joined existing investors Cahn Medical Technologies; Calvert Venture...
07:00 , Oct 8, 2001 |  BioCentury  |  Finance

Ebb & Flow

Whether it's a dead-cat bounce or the start of a rally, biotech has posted the best performance of the major indexes tracked by BioCentury over the past two weeks. Since Sept. 21 - the Friday...
07:00 , Oct 16, 2000 |  BioCentury  |  Regulation

Opening the door to off-patent biologics

WASHINGTON - Congress is likely to consider proposals next year to create clear regulatory pathways for approvals of off-patent, or follow-on versions of recombinant drugs and biologics. The generic drug industry and some consumer advocates...
08:00 , Nov 18, 1996 |  BioCentury  |  Emerging Company Profile

Advanced Therapies Inc.

Advanced Therapies Inc. Novato, Calif. Technology: Artificial Viral Envelope (AVE) vectors for delivery of protein, peptide, and DNA therapeutics Disease focus: N/A Clinical status: Preclinical Founded: 1993 by Hans Schreier and Pascal Druzgala Corporate partners:...